BioGaia probiotic found to prevent recurrent diarrhea and promote growth in children

a56e4159-6c57-45b5-bc01-710f73a4865darticleimage.jpg

07 Nov 2017 --- Rapid diagnostic testing in combination with Lactobacillus reuteri Protectis supplementation for 60 days has been linked to a significant increase in height and significantly less recurrent diarrhea in study of 71 infants with acute diarrhea, as compared to standard care and placebo treatment. Lactobacillus reuteri Protectis is a strain developed by Swedish healthcare company BioGaia.

“These results are very exciting. Our trial has shown that the administration of L. reuteri DSM 17938 shows real promise to mitigate the devastating effects of diarrheal disease in sub-Saharan Africa,” says Associate Professor Jeffrey Pernica at McMaster Children’s Hospital in Hamilton, Canada, lead investigator of the study.

“Previous probiotic trials have focused on outcomes such as duration of diarrhea, which are somewhat relevant for families and clinicians, but not nearly as important as a hard outcome such as standardized height, which has been directly linked to stunting, cognitive deficiencies, and eventual adult accomplishment,” Pernica explains. “The combination of test-and-treat diagnostics and L. reuteri DSM 17938 was associated with 93 percent lower odds of recurrent diarrhea in the 60-day follow-up period, as well as a dramatic increase in age-standardized height.”

Diarrhea kills and disables children
Diarrhea is the second-leading cause of mortality in the world among children under the age of 5, as well as a major cause of both growth failure and impaired cognitive development. There is a clear need for improvements in diarrheal disease management in resource-limited settings.

The pilot study was conducted in Botswana and demonstrated that the use of molecular rapid enteric diagnostics (permitting timely targeted antimicrobial therapy) and the administration of L. reuteri Protectis were both feasible in a resource-limited sub-Saharan African context. These interventions led to significant increases in growth and decreases in recurrent diarrhea. The next step will be to validate these findings in a trial with a much larger number of children.

BioGaia first announced the results in October 2015 when the study was presented for the first time at The Infectious Disease Week in San Diego, USA, but the findings were published in PLOS ONE on 9 October.

“We had announced the results of this study already, in October 2015, but now have the opportunity to highlight them again. The fact that L. reuteri Protectis may mitigate terrible consequences of diarrheal disease, like stunting, cognitive deficiencies, and eventual adult accomplishments, and contribute to a decrease in recurrent diarrhea, increased growth and improved quality of life for children in sub-Saharan countries is very encouraging”, says Axel Sjöblad, Managing Director at BioGaia.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Navigating the digestive health space: Probiotic strain specificity and microbiome key to future NPD

16 Nov 2018 --- Emerging science linking a healthy microbiome to nearly every facet of health, as well as the ongoing media reporting on probiotics, have helped drive consumer interest in gut health. This growing area offers a wealth of opportunities to formulators, but due to regulatory demands and increasing consumer scrutiny, a clear view of how to navigate this space is vital.

Health & Nutrition News

Kellogg’s debuts gut-boosting cereal with prebiotics, probiotics and fiber

15 Nov 2018 --- Kellogg’s has launched a “3-in-1” cereal aimed at making digestive wellness support easily accessible in food. The new wellness brand HI! Happy Inside delivers prebiotics, probiotics and fiber in an all-in-one cereal. The launch comes at a time when interest in digestive health seems to only continue to grow.

Health & Nutrition News

Experts weigh in on digestive health in Kerry Health and Nutrition Institute webinar

14 Nov 2018 --- Gut health is becoming increasingly popular among consumers. In this wide-ranging health area, the gut-brain axis (GBA) is a key area of interest, along with the sort of probiotic bacteria that aid wider gut health, Dairy & Food Culture Technologies Consultant, Dr. Mary Ellen Sanders, tells NutritionInsight. Sanders will be presenting a Kerry Health and Nutrition Institute webinar today hosted on FoodIngredientsFirst.com.

Packaging & Technology News

Consumer interest in liquid nutraceutical delivery forms grow as “pill fatigue” perseveres, says Bormioli Pharma 

13 Nov 2018 --- Consumers are more mindful of their health and nutraceutical products have become aspects of an everyday diet. This, coupled with a faster pace of consumer living has spurred a number of packaging innovations for nutraceuticals. This is according to Elena Piazza, Business Development & Marketing Manager at Bormioli Pharma, which supplies pharmaceutical and nutraceutical packaging solutions. Its portfolio includes a dual chamber system packaging which offers precise reconstitution for oral products, including food supplements.

Packaging & Technology News

Instant-mix cap: Karma-Aptar collaboration targets personalized, fortified nutrition trend

12 Nov 2018 --- Creators of the Karma Push Cap Technology, Karma, have formed a collaboration with Aptar Food + Beverage, a global specialist in dispensing, sealing and active packaging solutions, to deliver instant-mix technology to a range of market segments focused on the rising trend of personalized, fortified nutrition. The collaboration believes that the cap has the potential to extend beyond beverage into other industries, including medical and pharmaceutical.

More Articles
URL : http://www.nutritioninsight.com:80/news/biogaias-probiotic-found-to-prevent-recurrent-diarrhea-and-promote-growth-in-children.html